Great Diamond Partners’s Boston Scientific BSX Stock Holding History

Great Diamond Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,383	Closed	-$227K	–	233
2025 Q4	$227K	Sell	2,383 -175	-7%	-$17.2K	0.04%	215
2025 Q3	$250K	Sell	2,558 -103	-4%	-$10.7K	0.05%	205
2025 Q2	$286K	Sell	2,661 -197	-7%	-$19.9K	0.06%	190
2025 Q1	$288K	Buy	+2,858	New	+$288K	0.08%	144
2020 Q1	–	Sell	-1,368	Closed	-$61K	–	186
2019 Q4	$61K	Buy	+1,368	New	+$57.2K	0.02%	276

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Great Diamond Partners's BSX Position: Q1 2026 in Review

Great Diamond Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,383 shares — an estimated $227K sold.

Great Diamond Partners first reported a position in BSX in Q4 2019 and held it in 5 quarters. The position peaked at $288K in Q1 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Great Diamond Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Great Diamond Partners sold 2,383 Boston Scientific shares in Q1 2026, an estimated $227K.
Great Diamond Partners first reported a position in Boston Scientific in Q4 2019 and held it in 5 quarters.
Great Diamond Partners's Boston Scientific position peaked at $288K in Q1 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Great Diamond Partners's 13F filing for Q1 2026, filed 12 May 2026.